1. Cho WS, Hong HS, Kang HS, Kim JE, Cho YD, Kwon OK, et al. Stability of cerebral aneurysms after stent-assisted coil embolization: a propensity score-matched analysis. Neurosurgery. 77:208–216. 2015.
2. Hwang G, Huh W, Lee JS, Villavicencio JB, Villamor RB Jr, Ahn SY, et al. Standard vs modified antiplatelet preparation for preventing thromboembolic events in patients with high on-treatment platelet reactivity undergoing coil embolization for an unruptured intracranial aneurysm: a randomized clinical trial. JAMA Neurol. 72:764–772. 2015.
3. Hwang G, Kim JG, Song KS, Lee YJ, Villavicencio JB, Suroto NS, et al. Delayed ischemic stroke after stent-assisted coil placement in cerebral aneurysm: characteristics and optimal duration of preventative dual antiplatelet therapy. Radiology. 273:194–201. 2014.
4. Kim CH, Hwang G, Kwon OK, Ban SP, Chinh ND, Tjahjadi M, et al. P2Y12 reaction units threshold for implementing modified antiplatelet preparation in coil embolization of unruptured aneurysms: a prospective validation study. Radiology. 282:542–551. 2017.
5. Kim KS, Fraser JF, Grupke S, Cook AM. Management of antiplatelet therapy in patients undergoing neuroendovascular procedures. J Neurosurg. 129:890–905. 2018.
6. Kim MS, Jo KI, Yeon JY, Kim JS, Kim KH, Jeon P, et al. Safety and efficacy of antiplatelet response assay and drug adjustment in coil embolization: a propensity score analysis. Neuroradiology. 58:1125–1134. 2016.
7. Kim T, Kim CH, Kang SH, Ban SP, Kwon OK. Relevance of antiplatelet therapy duration after stent-assisted coil embolization for unruptured intracranial aneurysms. World Neurosurg. 116:e699–e708. 2018.
8. Lijnen HR, Collen D. Endothelium in hemostasis and thrombosis. Prog Cardiovasc Dis. 39:343–350. 1997.
9. Matsumoto Y, Nakai K, Tsutsumi M, Iko M, Nii K, Narita S, et al. Onset time of ischemic events and antiplatelet therapy after intracranial stent-assisted coil embolization. J Stroke Cerebrovasc Dis. 23:771–777. 2014.
10. Mehran R, Rao SV, Bhatt DL, Gibson CM, Caixeta A, Eikelboom J, et al. Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium. Circulation. 123:2736–2747. 2011.
11. Mocco J, Fargen KM, Albuquerque FC, Bendok BR, Boulos AS, Carpenter JS, et al. Delayed thrombosis or stenosis following enterprise-assisted stent-coiling: is it safe? Midterm results of the interstate collaboration of enterprise stent coiling. Neurosurgery. 69:908–913. discussion 913-914. 2014.
12. Rossen JD, Chalouhi N, Wassef SN, Thomas J, Abel TJ, Jabbour PM, et al. Incidence of cerebral ischemic events after discontinuation of clopidogrel in patients with intracranial aneurysms treated with stent-assisted techniques. J Neurosurg. 117:929–933. 2012.
13. Roy D, Milot G, Raymond J. Endovascular treatment of unruptured aneurysms. Stroke. 32:1998–2004. 2001.
14. Shoda K, Enomoto Y, Egashira Y, Kinoshita T, Mizutani D, Iwama T. Long-term complications after stent assist coiling dependent on clopidogrel response. BMC Neurol. 21:247. 2021.
15. Song J, Yeon JY, Kim JS, Hong SC, Kim KH, Jeon P. Delayed thromboembolic events more than 30 days after self expandable intracranial stent-assisted embolization of unruptured intracranial aneurysms. Clin Neurol Neurosurg. 135:73–78. 2015.
16. Tantry US, Bonello L, Aradi D, Price MJ, Jeong YH, Angiolillo DJ, et al. Consensus and update on the definition of on-treatment platelet reactivity to adenosine diphosphate associated with ischemia and bleeding. J Am Coll Cardiol. 62:2261–2273. 2013.
17. Tateshima S, Tanishita K, Hakata Y, Tanoue SY, Viñuela F. Alteration of intraaneurysmal hemodynamics by placement of a self-expandable stent. Laboratory investigation. J Neurosurg. 111:22–27. 2009.
18. Yang H, Li Y, Jiang Y. Insufficient platelet inhibition and thromboembolic complications in patients with intracranial aneurysms after stent placement. J Neurosurg. 125:247–253. 2016.